ClinicalTrialsFinder

CD20-positive Acute Lymphoblastic Leukemia Clinical Trials in Bialystok

1 recruitingBialystok, Poland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"

CD20-positive Acute Lymphoblastic Leukemia
Maria Sklodowska-Curie National Research Institute of Oncology124 enrolled19 locationsNCT04920968